Similar articles

• [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].

  Bbukowska D, Serafińska D, Rudowski W, Hoffman S, Olański W, Gardzińska E, Popiel D, Jedrzejczak G, Czarnecka I. Bbukowska D, et al. Pol Tyg Lek. 1989 Oct 23-Nov 6;44(43-45):924-7. Pol Tyg Lek. 1989. PMID: 2518666 Clinical Trial. Polish.
• [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland].

  Bukowska D, Serafińska D, Zietkiewicz W, Rudowski W, Hoffman S, Uszyński H, Molski M, Hess C, Jonecko A, Popiel D, et al. Bukowska D, et al. Pol Tyg Lek. 1986 Dec 8;41(49):1549-52. Pol Tyg Lek. 1986. PMID: 3108869 Polish. No abstract available.
• [Clinical use of a Soviet polyvalent corpuscular pyocyanic vaccine for the prevention of Pseudomonas aeruginosa infection in thermal burn victims].

  Gerasimova LI, Moroz AF, Radkevich SA, Sveshnikov AI, Mizikin EV. Gerasimova LI, et al. Khirurgiia (Mosk). 1980 Nov;(11):36-41. Khirurgiia (Mosk). 1980. PMID: 6777578 Clinical Trial. Russian. No abstract available.
• Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.

  Meitert E, Meitert T, Sima F, Savulian C. Meitert E, et al. Arch Roum Pathol Exp Microbiol. 1982 Apr-Jun;41(2):105-14. Arch Roum Pathol Exp Microbiol. 1982. PMID: 6816188 Review. No abstract available.
• Pseudomonas aeruginosa: the potential to immunise against infection.

  Sedlak-Weinstein E, Cripps AW, Kyd JM, Foxwell AR. Sedlak-Weinstein E, et al. Expert Opin Biol Ther. 2005 Jul;5(7):967-82. doi: 10.1517/14712598.5.7.967. Expert Opin Biol Ther. 2005. PMID: 16018741 Review.